Insights

Why Life Sciences Companies Should Stay with Salesforce HLS Post-Veeva Split

By Christopher Hunter
Published on September 16, 2025 5 minute read
Practical ERP Solutions Background
The upcoming separation between Salesforce and Veeva in September 2025 presents an important crossroad for life sciences companies currently using Veeva Vault CRM. With Veeva moving to its own platform, businesses must decide whether to stay on Salesforce or migrate to Veeva Vault CRM. While Veeva Vault offers specialized features for the life sciences sector, Salesforce Health and Life Sciences (HLS) provides a wealth of technical and business process advantages that can significantly benefit organizations, especially in terms of cost savings, operational efficiency, and innovation. Here’s why staying on Salesforce HLS is the best decision for life sciences companies.

Comprehensive Salesforce HLS Capabilities

  1. Salesforce HLS provides a single platform that unites various departments and functions, allowing life sciences companies to break down silos and enhance collaboration across teams such as sales, marketing, clinical, and medical affairs. Unlike Veeva Vault, which focuses primarily on CRM for sales teams, Salesforce HLS integrates not just customer data but clinical trial data, regulatory affairs, and patient information, providing a complete and unified view of both commercial and clinical operations.
    • Commercial Operations: Salesforce HLS seamlessly integrates Salesforce automation (SFA), customer relationship management (CRM), and marketing automation to streamline operations.
    • Clinical Operations: It connects clinical trials, investigator relations, and patient management systems with sales data, allowing life sciences companies to coordinate their efforts across the full spectrum of business functions.
    • Medical Affairs: With the integration of Salesforce’s Einstein AI and Tableau, teams can gain real-time insights into patient data, which can inform both commercial and clinical strategies.

    Operational Efficiency and Cost Savings

  2. Switching platforms can be costly. Migrating to Veeva Vault CRM involves expenses for data migration, system integration, and employee retraining. Salesforce HLS allows life sciences companies to avoid these transition expenses by staying on a familiar platform that already supports a broad range of functionalities.

    Salesforce HLS comes with industry-specific features built directly into the platform, reducing the need for extensive customization. The pre-configured solutions make it easier for companies to scale their CRM without the added financial burden of switching platforms. Staying on Salesforce HLS also means not having to maintain two separate platforms, one for clinical data and one for commercial data, which reduces overhead costs and administrative complexity.

    Scalability and Customization

  3. Salesforce HLS provides unparalleled scalability, which is critical for life sciences companies aiming to expand or adapt to changing industry needs. Salesforce HLS supports organizations of all sizes, from startups to global enterprises. Its flexible architecture allows for rapid customization, enabling businesses to tailor their solutions to their specific needs.

    In addition to scalability, Salesforce HLS offers integration with over 1,000 third-party apps on the Salesforce AppExchange, making it easy to add new functionalities as companies grow. Whether integrating with electronic health records (EHR) systems, laboratory information management systems (LIMS), or financial ERP systems, Salesforce makes it easy to connect disparate systems for a comprehensive view of operations.

    Powerful Analytics and AI-Driven Insights

  4. Salesforce HLS harnesses the advanced capabilities of Salesforce Einstein to drive intelligent decision-making across both commercial and clinical operations. Far beyond traditional CRM functionality, Einstein delivers predictive analytics, machine learning, and automated reporting — empowering life sciences organizations to act on real-time, data-driven insights.

    By anticipating patient behaviors and treatment outcomes, Einstein enables medical affairs teams to refine clinical trial targeting and helps sales teams prioritize high-value leads. This forward-looking approach keeps companies ahead of evolving market dynamics and regulatory shifts, enhancing strategic agility and operational performance.

    Enhanced Data Visualization with Tableau

  5. The integration of Tableau within Salesforce HLS elevates data visualization and reporting capabilities, enabling life sciences teams to build interactive dashboards tailored to their operational needs. From monitoring clinical trial progress and sales performance to analyzing patient engagement, Tableau delivers clear, actionable insights that support informed decision making. Remaining on Salesforce ensures continued access to these advanced analytics tools — without the disruption or complexity of switching platforms.

    Regulatory Compliance and Security

  6. In the healthcare and life sciences sectors, where regulatory oversight is stringent, safeguarding data and maintaining compliance with standards such as HIPAA, 21 CFR Part 11, and FDA guidelines is essential. Salesforce HLS is purpose-built to meet these demands, offering embedded features like audit trails, role-based access controls, and robust data encryption. Backed by a proven track record in security and regulatory compliance, Salesforce provides life sciences organizations with a trusted platform to protect sensitive patient information while adhering to industry mandates.

The Strategic Advantage of Staying on Salesforce HLS

While Veeva Vault CRM is tailored specifically for the life sciences sector, Salesforce HLS offers a unified, scalable, and flexible platform that delivers both business processes and technical advantages. Its ability to reduce costs, streamline integrations, and provide advanced analytics and compliance tools makes it a powerful foundation for long-term growth and innovation.

As the Veeva-Salesforce separation approaches, staying with Salesforce HLS emerges as a strategic decision that ensures continuity, scalability, and innovation in a rapidly evolving healthcare landscape.

To make the most of this transition, we encourage life sciences organizations to consult with our Salesforce professionals. Our team is ready to guide you through tailored solutions that align with your business goals and regulatory needs, helping you stay ahead in a competitive market.